Literature DB >> 10906766

Argatroban as an anticoagulant for both hematologic and chemical tests.

T Kumura1, M Hino, T Yamane, N Tatsumi.   

Abstract

Argatroban possesses strong antithrombin-like activity. We evaluated the usefulness of argatroban in anticoagulating specimens for routine laboratory tests. Results using blood anticoagulated with argatroban corresponded well with the results of blood treated with ethylendiamine tetra-acetic acid (EDTA) in the complete blood count (CBC), including the WBC differential count and morphology of blood cells, when the CBC was performed within 2 hr of blood collection. Clinical chemistry results from argatroban-treated samples were similar to results obtained with serum specimens. Thus, argatroban may be a useful anticoagulant for emergency laboratory medicine. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906766      PMCID: PMC6808022          DOI: 10.1002/1098-2825(2000)14:4<136::aid-jcla2>3.0.co;2-1

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Excessive blood drawing for laboratory tests.

Authors:  J M Hicks
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

2.  In vitro and in vivo studies of a new series of synthetic thrombin-inhibitors (OM-inhibitors).

Authors:  A Hijikata; S Okamoto; E Mori; K Kinjo; R Kikumoto
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

3.  A new series of synthetic thrombin-inhibitors (OM-inhibitors) having extremely potent and selective action.

Authors:  S Okamoto; A Hijikata; K Ikezawa; K Kinjo; R Kikumoto
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

Review 4.  Development of argatroban, a direct thrombin inhibitor, and its clinical application.

Authors:  T Matsuo; M Koide; K Kario
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

Review 5.  Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis.

Authors:  Y Tamao; R Kikumoto
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

Review 6.  Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.

Authors:  M J Hursting; K L Alford; J C Becker; R L Brooks; J L Joffrion; G D Knappenberger; P W Kogan; T P Kogan; A A McKinney; R P Schwarz
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

7.  Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis.

Authors:  S Kobayashi; Y Tazaki
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

8.  Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.

Authors:  T Kumada; Y Abiko
Journal:  Thromb Res       Date:  1981-11-15       Impact factor: 3.944

9.  Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion.

Authors:  S Okamoto; A Hijikata; R Kikumoto; S Tonomura; H Hara; K Ninomiya; A Maruyama; M Sugano; Y Tamao
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

10.  Thrombin-induced vasoconstriction in isolated cerebral arteries and the influence of a synthetic thrombin inhibitor.

Authors:  K Nakamura; Y Hatano; K Mori
Journal:  Thromb Res       Date:  1985-12-01       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.